Post-approval studies (Phase 4)Looking for participantsNCT07323524What this trial is testingDapagliflozin in Active Lupus NephritisWho this might be right forLupus Nephritis (LN) Brigham and Women's Hospital 33
Not applicableWithdrawnNCT00908986What this trial is testingOpen Label Pilot Trial of Rituximab in Lupus Membranous NephritisWho this might be right forLupus Nephritis Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT06419205What this trial is testingEvaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GWho this might be right forIgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy Akebia Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT07570862What this trial is testingA Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisWho this might be right forLupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more Fate Therapeutics 53
Not applicableUnknownNCT06379646What this trial is testingAn Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseWho this might be right forSystemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT02472795What this trial is testingClinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Viatris Innovation GmbH 105
Very early researchNot Yet RecruitingNCT07266337What this trial is testingCD19/BCMA CAR-T for SLEWho this might be right forSLE - Systemic Lupus Erythematosus Chengdu Ucello Biotechnology Co., Ltd. 24
Early research (Phase 1)Study completedNCT04136145What this trial is testingSingle Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 36
Large-scale testing (Phase 3)Study completedNCT05326841What this trial is testingEffect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .Who this might be right forLupus Erythematosus, SystemicCholecalciferol SupplementationDisease Activity+1 more Dr Cipto Mangunkusumo General Hospital 60
Not applicableUnknownNCT05632029What this trial is testingLaser Acupuncture in Egyptian Systemic Lupus Females With Insulin ResistanceWho this might be right forSystemic Lupus ErythematosusPreDiabetes Cairo University 64
Early research (Phase 1)WithdrawnNCT06411639What this trial is testingPharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWho this might be right forSjogren DiseaseSystemic Lupus Erythematosus Novartis Pharmaceuticals
Very early researchNot Yet RecruitingNCT06886919What this trial is testingClinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus ErythematosusWho this might be right forDifficult to Treat Systemic Lupus Erythematosus Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT03453619What this trial is testingPhase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesWho this might be right forIgA NephropathyLupus NephritisMembranous Nephropathy+2 more Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT06113900What this trial is testingAssessment of Safety and Efficacy of SGLT2is Among LN PatientsWho this might be right forLupus Nephritis Ain Shams University 50
Early research (Phase 1)Study completedNCT00705367What this trial is testingPhase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kgWho this might be right forLupus Nephritis Bristol-Myers Squibb 13
Not applicableWithdrawnNCT04369495What this trial is testingBAFF Levels and Lupus Nephritis (LN)Who this might be right forLupus Nephritis Universidad de Antioquia
Not applicableNot Yet RecruitingNCT07183007What this trial is testingDevelopment of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus PatientsWho this might be right forSystemic Lupus Erythematosus Universitas Indonesia 100
Large-scale testing (Phase 3)UnknownNCT04275193What this trial is testingThe Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Shanghai University of Traditional Chinese Medicine 118
Testing effectiveness (Phase 2)Looking for participantsNCT06897930What this trial is testingInvestigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLEWho this might be right forLupus Erythematosus, Systemic AstraZeneca 150
Not applicableLooking for participantsNCT01510067What this trial is testingPrevalence and Clinical Severity of Cutaneous Lupus ErythematosusWho this might be right forCutaneous Lupus Erythematosus (CLE) University of Pennsylvania 700